Evaluating the cost-effectiveness of testing pregnant women for penicillin allergy

• DOI: 10.1371/journal.pone.0280151
• Publication Date: 2023-01-20T18:52:15Z
• Authors: Viengneesee Thao; Emily E. Sharpe; Ruchita Dholakia; Hannah H. Ahn; James P. Moriarty; Bijan J. Borah; Margaret C. Gill; Regan N. Theiler
• Keywords: Penicillin allergy

True penicillin allergy is rare and commonly incorrectly reported. In fact, less than five percent of patients who report a will have currently active clinically-significant IgE- or T-cell-mediated hypersensitivity when appropriately tested. Penicillin the agent choice for intrapartum antibiotic prophylaxis to reduce risk group B streptococcus early-onset disease in newborn. Inaccurate status may lead inappropriate use, as most alternative drugs are more expensive broader spectrum penicillin. testing has been found be safe pregnancy cost-effective other patient populations.